Clinical significance of tumor markers and an emerging perspective on colorectal cancer.
about
ASAP3 upregulation contributes to colorectal carcinogenesis and indicates poor survival outcomeCancer cell-specific oligopeptides selected by an integrated microfluidic system from a phage display library for ovarian cancer diagnosis.Role of inflammation and inflammatory mediators in colorectal cancerSerum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study.MiR-194 deregulation contributes to colorectal carcinogenesis via targeting AKT2 pathway.Detection of methylated CDO1 in plasma of colorectal cancer; a PCR study.Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients.Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.In vitro autoradiography of carcinoembryonic antigen in tissue from patients with colorectal cancer using multifunctional antibody TF2 and (67/68Ga)-labeled haptens by pretargeting.The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer.CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis.Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers.Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study.Telomeres and telomerase in the clinical management of colorectal cancer.Different clinical characteristics in sporadic young-age onset colorectal cancer.High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis.Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method.Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients.Evaluation of peritoneal CEA levels following colorectal cancer surgery.RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer.The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study.Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer.Nodule and eminence on frenulum labii superioris: diagnostic markers for metastatic colorectal cancer.Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.The Immunome of Colon Cancer: Functional In Silico Analysis of Antigenic Proteins Deduced from IgG Microarray Profiling.Peripheral blood guanylyl cyclase c (GCC) expressions are associated with prognostic parameters and response to therapy in colorectal cancer patients.Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas.
P2860
Q30008732-11C60B76-CF9A-42BB-873C-408648E9F83CQ30418500-28FD379C-4FB9-4C57-9FCC-3757963A8496Q33957824-F575EEAD-E0ED-4D49-A298-1B47C46D2321Q33983058-D0F498CE-B436-4A7A-B99F-95C5F64DF484Q34284409-46487DF3-BB32-4EBF-A3D7-235FDF9C8CEFQ34623966-ED5DCBF9-D9A6-4A70-BE59-E999642F0EE2Q34727224-633B50EF-6777-4233-B1FC-24D932C01961Q36172719-47B585BA-CA65-4A63-A1E2-3041604BDC0DQ36337238-AE942756-31AA-4E33-B93F-D8F6E1619AF8Q36739523-8A9E4913-5CE1-4802-8A31-9DDC5EFE05DCQ37591247-B3EEBE72-D144-452A-97E2-AB17E37317FFQ37728199-7F03351D-8677-4737-B3B5-074C3BF180CFQ38825662-54E2F776-78CA-4E0A-8807-3CFBCDEE2940Q38985823-0D493832-1957-49DB-BEF5-4BB5002646D5Q39387446-AA579E84-9A83-4993-9BF0-BECCA8EA5346Q40548381-0947502F-1D0E-4E79-928B-194DE059D15EQ41127993-BBEDE513-C21C-44AE-BD2F-F7444E8EC68EQ41753905-AC51998E-77B9-4769-8CC2-C18A4586E15CQ42267500-2353827D-8060-4507-8FED-F0EF1EE831F2Q44176691-1317B87A-2A69-43F8-B1D3-52B170736AF5Q45222109-015C263B-65F2-4BD2-9F6A-AD35934154A3Q46959484-C76CA657-0241-4C8D-9765-3BC65064BCE4Q50566746-E091FBF6-55DD-4941-B17E-4538A0A11067Q50657266-8F553CD2-00DF-43B2-B4C8-9D86D050B238Q50666500-3DEC2D02-F6C3-4921-86FB-EB188591326DQ51549059-215680F0-0418-4253-8CA1-65BA0892B97CQ52367069-ACE3B290-F06E-46F1-A744-6A4912738408Q54350042-FB66E039-D158-4755-8C48-3FBA8098C69EQ55250506-B0872293-9BFC-4CF7-BF3E-18B51F598FB6
P2860
Clinical significance of tumor markers and an emerging perspective on colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical significance of tumor markers and an emerging perspective on colorectal cancer.
@en
Clinical significance of tumor markers and an emerging perspective on colorectal cancer.
@nl
type
label
Clinical significance of tumor markers and an emerging perspective on colorectal cancer.
@en
Clinical significance of tumor markers and an emerging perspective on colorectal cancer.
@nl
prefLabel
Clinical significance of tumor markers and an emerging perspective on colorectal cancer.
@en
Clinical significance of tumor markers and an emerging perspective on colorectal cancer.
@nl
P2860
P1433
P1476
Clinical significance of tumor markers and an emerging perspective on colorectal cancer.
@en
P2093
Keishi Yamashita
Masahiko Watanabe
P2860
P304
P356
10.1111/J.1349-7006.2008.01022.X
P577
2009-02-01T00:00:00Z